TheraRadar

Hepatology Drugs

46 FDA-approved drugs

TheraRadar tracks 46 FDA-approved hepatology drugs from 31 companies across 7 drug classes, led by Teva, with 115 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Hepatology.

Hepatology Approvals by Year

2
'15
4
'16
1
'17
3
'18
2
'19
'20
2
'21
'22
1
'23
3
'24
1
'25
'26

Recent Hepatology Drug Approvals

DOPTELET SPRINKLE
AVATROMBOPAG MALEATE
thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedu...
2025-07-24
AKARX INC
LIVDELZI
SELADELPAR LYSINE
primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have...
2024-08-14
Gilead Sciences
IQIRVO
ELAFIBRANOR
primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have...
2024-06-10
IPSEN
REZDIFFRA
RESMETIROM
REZDIFFRA is indicated in conjunction with diet and exercise for the treatment of adults with noncir...
2024-03-14
MADRIGAL
OBETICHOLIC ACID
OBETICHOLIC ACID
2023-05-30
Apotex
LIVMARLI
MARALIXIBAT CHLORIDE
cholestatic pruritus in patients 3 months of age and older with Alagille syndrome (ALGS)...
2021-09-29
MIRUM
BYLVAY
ODEVIXIBAT
pruritus in patients 3 months of age and older with PFIC...
2021-07-20
IPSEN
NOURESS
CYSTEINE HYDROCHLORIDE
2019-12-13
Baxter
ELCYS
CYSTEINE HYDROCHLORIDE
use as an additive to amino acid solutions to meet the nutritional requirements of newborn infants r...
2019-04-16
EXELA PHARMA
MULPLETA
LUSUTROMBOPAG
thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedu...
2018-07-31
VANCOCIN ITALIA
OMEGAVEN
FISH OIL TRIGLYCERIDES
the prevention of PNAC...
2018-07-27
Fresenius Kabi
DOPTELET
AVATROMBOPAG MALEATE
thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedu...
2018-05-21
AKARX INC
JADENU SPRINKLE
DEFERASIROX
chronic iron overload due to blood transfusions in patients 2 years of age and older...
2017-05-18
Novartis
SMOFLIPID 20%
FISH OIL
the prevention of PNAC...
2016-07-13
Fresenius Kabi
OCALIVA
OBETICHOLIC ACID
2016-05-27
INTERCEPT
DEFITELIO
DEFIBROTIDE SODIUM
adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obs...
2016-03-30
JAZZ PHARMS
TNF
CETYLEV
ACETYLCYSTEINE
2016-01-29
ARBOR PHARMS LLC
JADENU
DEFERASIROX
chronic iron overload due to blood transfusions in patients 2 years of age and older...
2015-03-30
Novartis
CHOLBAM
CHOLIC ACID
bile acid synthesis disorders due to single enzyme defects (SEDs)...
2015-03-17
MIRUM
EOVIST
GADOXETATE DISODIUM
use in magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adult and...
2008-07-03
Bayer
Showing the 20 most recent of 46 hepatology drugs. View all 46 →

Hepatology Active Trials by Indication

115 active trials — the forward pipeline, not just approvals.

All competitive landscapes →

Hepatology Drug Classes

Iron Chelator 3
Antidote 2
Osmotic Laxative 2
Peroxisome Proliferator-activated Receptor Agonist 1
Thyroid Hormone Receptor beta Agonist 1
Ileal Bile Acid Transporter Inhibitor 1
Bile Acid 1

Hepatology at a Glance

Total Drugs
46
Companies
31
Drug Classes
7
Active Trials
115
Latest Approval
2025-07-24